Literature DB >> 26344186

Does HbF induction by hydroxycarbamide work through MIR210 in sickle cell anaemia patients?

Madhavi Sawant1, Chandrakala S2, Roshan Colah1, Kanjaksha Ghosh1, Anita Nadkarni3.   

Abstract

Entities:  

Keywords:  HBG2; HbF; MIR210; hydroxycarbamide; sickle cell anaemia

Mesh：

Substances：

Year:  2015        PMID： 26344186     DOI： 10.1111/bjh.13642

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Elevated levels of miR-210 correlate with anemia in β-thalassemia/HbE patients.

Authors:  Panjaree Siwaponanan; Suthat Fucharoen; Pornpan Sirankapracha; Pranee Winichagoon; Tsukuru Umemura; Saovaros Svasti
Journal:  Int J Hematol       Date:  2016-06-06       Impact factor: 2.490

2.  Synergistic effect of two β globin gene cluster mutations leading to the hereditary persistence of fetal hemoglobin (HPFH) phenotype.

Authors:  Priya Hariharan; Madhavi Sawant; Manju Gorivale; Ruma Manchanda; Roshan Colah; K Ghosh; Anita Nadkarni
Journal:  Mol Biol Rep       Date:  2017-09-06       Impact factor: 2.316

3.  BCL11A mRNA Targeting by miR-210: A Possible Network Regulating γ-Globin Gene Expression.

Authors:  Jessica Gasparello; Enrica Fabbri; Nicoletta Bianchi; Giulia Breveglieri; Cristina Zuccato; Monica Borgatti; Roberto Gambari; Alessia Finotti
Journal:  Int J Mol Sci       Date:  2017-11-26       Impact factor: 5.923

Review 4.  Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option.

Authors:  Athena Starlard-Davenport; Qingqing Gu; Betty S Pace
Journal:  Mol Diagn Ther       Date:  2022-05-12       Impact factor: 4.476

5.  New Insights Into Pathophysiology of β-Thalassemia.

Authors:  Maria Sanchez-Villalobos; Miguel Blanquer; Jose M Moraleda; Eduardo J Salido; Ana B Perez-Oliva
Journal:  Front Med (Lausanne)       Date:  2022-04-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.